Since the introduction of substance patents in Korea, many pharmaceutical companies have made efforts to develop new drugs, and as a result, many new drugs have been launched in Korea. Since then, various researches such as new drugs, biopharmaceuticals, herbal medicines, medical devices, and functional foods have been conducted, making it a global pharmaceutical powerhouse. Therefore, in order to achieve the greater goal of global new drug development, Korea is urgently required a strategy to secure international reliability and minimize time and cost by conducting non-clinical trials that meet global standards.
Accordingly, the quality of domestic non-clinical trials is improving day by day with the introduction of GLP in 1988, mutual certification of OECD in 1996, mutual certification of OECD in 2001, and introduction of compulsory non-clinical GLP in 2003.
The Korean Society of Nonclinical Study
